| scholarly article | Q13442814 |
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | World Health Organization | Q7817 |
| pneumococcal vaccine | Q14538008 | ||
| P304 | page(s) | 129-44 | |
| P577 | publication date | 2012-04-06 | |
| P1433 | published in | Weekly Epidemiological Record | Q26842229 |
| P1476 | title | Pneumococcal vaccines WHO position paper--2012 | |
| P478 | volume | 87 |
| Q38246355 | 10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children |
| Q33612471 | A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine |
| Q55107951 | A novel extracellular vesicle-associated endodeoxyribonuclease helps Streptococcus pneumoniae evade neutrophil extracellular traps and is required for full virulence. |
| Q34184995 | A population-based study on the impact of hospitalization for pneumonia in different age groups |
| Q33848708 | A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009-2016) |
| Q92876384 | A systematic literature review and network meta-analysis feasibility study to assess the comparative efficacy and comparative effectiveness of pneumococcal conjugate vaccines |
| Q46987999 | Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy |
| Q33776584 | Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya |
| Q30378618 | Association between community management of pneumonia and diarrhoea in high-burden countries and the decline in under-five mortality rates: an ecological analysis. |
| Q47668505 | Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain |
| Q52371735 | Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection. |
| Q35923822 | Biological challenges to effective vaccines in the developing world |
| Q37042911 | Blood stream infection is associated with altered heptavalent pneumococcal conjugate vaccine immune responses in very low birth weight infants |
| Q63866056 | Can pneumococcal meningitis surveillance be used to assess the impact of pneumococcal conjugate vaccine on total invasive pneumococcal disease? A case-study from South Africa, 2005–2016 |
| Q35990339 | Characterization of 19A-like 19F pneumococcal isolates from Papua New Guinea and Fiji |
| Q35092077 | Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo |
| Q55222259 | Corrigendum: Specific Antibody Deficiency: Controversies in Diagnosis and Management. |
| Q35186834 | Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children |
| Q37631215 | Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia |
| Q92968782 | Delivering vaccines for the prevention of pneumonia - programmatic and financial issues |
| Q33706645 | Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil |
| Q37627963 | Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children |
| Q37613616 | Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers |
| Q60302496 | Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis |
| Q26801433 | Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis |
| Q64256081 | Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review |
| Q33706016 | Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial |
| Q91908514 | Emerging diseases in Bangladesh: Current microbiological research perspective |
| Q92408934 | Epidemiology Characteristics of Streptococcus pneumoniae From Children With Pneumonia in Shanghai: A Retrospective Study |
| Q36215294 | Epidemiology and risk factors for pneumonia severity and mortality in Bangladeshi children <5 years of age before 10-valent pneumococcal conjugate vaccine introduction |
| Q34674212 | Epidemiology of Streptococcus pneumoniae Serogroup 6 Isolates from IPD in Children and Adults in Germany |
| Q37264943 | Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: A systematic literature review. |
| Q36800391 | Estimated hospitalization rate for diseases attributable to Streptococcus pneumoniae in the Veneto region of north-east Italy |
| Q46245846 | Estimating meningitis hospitalization rates for sentinel hospitals conducting invasive bacterial vaccine-preventable diseases surveillance |
| Q92921720 | Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy |
| Q52687609 | Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials. |
| Q37593418 | Evaluation of chest radiography, lytA real-time PCR, and other routine tests for diagnosis of community-acquired pneumonia and estimation of possible attributable fraction of pneumococcus in northern Togo |
| Q47289166 | Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010-2016. |
| Q37135413 | Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study |
| Q34487073 | Genomic analyses of pneumococci reveal a wide diversity of bacteriocins - including pneumocyclicin, a novel circular bacteriocin |
| Q35757571 | Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci |
| Q28075884 | Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries |
| Q41993540 | Heterologous prime-boost immunization with live SPY1 and DnaJ protein of Streptococcus pneumoniae induces strong Th1 and Th17 cellular immune responses in mice |
| Q35070146 | High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination. |
| Q36177143 | Hospitalizations and Deaths Because of Respiratory and Diarrheal Diseases Among Haitian Children Under Five Years of Age, 2011-2013. |
| Q38694284 | IL-8 and IP-10 expression from human bronchial epithelial cells BEAS-2B are promoted by Streptococcus pneumoniae endopeptidase O (PepO). |
| Q37320197 | Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review |
| Q64075963 | Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial |
| Q36822003 | Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants |
| Q34981631 | Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infants |
| Q36219932 | Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review. |
| Q35762530 | Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review |
| Q36229752 | Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis. |
| Q92375593 | Impact of vaccination delay on deaths averted by pneumococcal conjugate vaccine: Modeled effects in 8 country scenarios |
| Q57029624 | Impfungen für Mitarbeiter des Gesundheitswesens |
| Q37547817 | Indirect Effects of Pneumococcal Conjugate Vaccines in National Immunization Programs for Children on Adult Pneumococcal Disease. |
| Q28079486 | Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety |
| Q52718935 | Intracellular replication of Streptococcus pneumoniae inside splenic macrophages serves as a reservoir for septicaemia. |
| Q58596157 | Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation |
| Q58765727 | Invasive Streptococcus pneumoniae infection among hospitalized patients in Jingzhou city, China, 2010-2012 |
| Q37264972 | Issues in pediatric vaccine-preventable diseases in low- to middle-income countries |
| Q90356741 | Maternal immunisation to improve the health of HIV-exposed infants |
| Q26770693 | Methodological criticisms in the evaluation of Pneumococcal Conjugate Vaccine effectiveness |
| Q36395006 | Methods and challenges for the health impact assessment of vaccination programs in Latin America |
| Q39924276 | Molecular characteristics of penicillin-binding protein 2b, 2x and 1a sequences in Streptococcus pneumoniae isolates causing invasive diseases among children in Northeast China |
| Q40111117 | Molecular characterization of Streptococcus pneumoniae, particularly serotype19A/ST320, that emerged in Krasnoyarsk, Russia |
| Q40176294 | Mucin 1 protects against severe Streptococcus pneumoniae infection. |
| Q34890164 | Mucosal immunization with the live attenuated vaccine SPY1 induces humoral and Th2-Th17-regulatory T cell cellular immunity and protects against pneumococcal infection |
| Q50104669 | Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey. |
| Q34815797 | Nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among children from Brazil before the introduction of the 10-valent conjugate vaccine |
| Q36887903 | National Immunization Program in Iran: whys and why nots |
| Q38682554 | Overall effectiveness of pneumococcal conjugate vaccines: an economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy |
| Q90315421 | PCV13 vaccination impact: A multicenter study of pneumonia in 10 pediatric hospitals in Argentina |
| Q45427099 | Penicillin induces alterations in glutamine metabolism in Streptococcus pneumoniae |
| Q89701151 | Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001-2016 |
| Q36192851 | Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience |
| Q36274529 | Pneumococcal carriage among HIV infected children in Accra, Ghana |
| Q58588461 | Pneumococcal carriage among sickle cell disease patients in Accra, Ghana: Risk factors, serotypes and antibiotic resistance |
| Q26798168 | Pneumococcal disease and use of pneumococcal vaccines in Taiwan |
| Q37652657 | Pneumococcal prophages are diverse, but not without structure or history |
| Q33706775 | Pneumococcal serotypes and serogroups causing invasive disease in Pakistan, 2005-2013 |
| Q47162758 | Pneumococcal vaccination and chronic respiratory diseases |
| Q41687129 | Pneumococcal vaccination in autoimmune rheumatic diseases |
| Q34798448 | Pneumococcal vaccination: what have we learnt so far and what can we expect in the future? |
| Q26739685 | Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination |
| Q34123708 | Population biology of 225 serogroup 6 Streptococcus pneumoniae isolates collected in China |
| Q41986749 | Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population. |
| Q46247023 | Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2012 |
| Q34260771 | Randomized, open-label study of the impact of age on booster responses to the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in children in India. |
| Q60044251 | Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity |
| Q34402444 | Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe |
| Q36101864 | Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county |
| Q37267627 | Risk factors for community-acquired pneumonia in adults in Europe: a literature review |
| Q35824048 | Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya |
| Q54027297 | Safety and Immunogenicity of Pneumococcal Conjugate Vaccine in Preterm Infants: A Meta-Analysis |
| Q40062579 | Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine in Adults 50 to 65 Years of Age in India: An Open-Label Trial. |
| Q37356343 | Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China |
| Q40127024 | Safety and tolerability of 13-valent pneumococcal conjugate vaccine in healthy Chinese adults, children and infants |
| Q35004396 | Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites |
| Q40721116 | Serotypes and genotypes of Streptococcus pneumoniae isolates from Trinidad and Tobago |
| Q39321569 | Simultaneous Streptococcus pneumoniae empyema in fraternal twins |
| Q33711527 | Specific Antibody Deficiency: Controversies in Diagnosis and Management |
| Q48521617 | Streptococcus pneumoniae Attenuated Strain SPY1 with an Artificial Mineral Shell Induces Humoral and Th17 Cellular Immunity and Protects Mice against Pneumococcal Infection |
| Q33733347 | Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies |
| Q35990551 | Streptococcus pneumoniae and Haemophilus influenzae type b carriage in Chinese children aged 12-18 months in Shanghai, China: a cross-sectional study |
| Q36788003 | Sublingual immunotherapy as an alternative to induce protection against acute respiratory infections |
| Q35886931 | Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia |
| Q37309181 | Surveillance of the impact of pneumococcal conjugate vaccines in developing countries |
| Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
| Q34512593 | The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe |
| Q35887754 | The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program |
| Q30377116 | The health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) during an annual influenza epidemic and influenza pandemic in China |
| Q33610320 | The impact of residency and urbanicity on Haemophilus influenzae Type b and pneumococcal immunization in Shanghai Children: a Retrospective Cohort Study |
| Q55315176 | Towards the introduction of pneumococcal conjugate vaccines in Bhutan: A cost-utility analysis to determine the optimal policy option. |
| Q35659734 | Vaccination Coverage and Compliance with Three Recommended Schedules of 10-Valent Pneumococcal Conjugate Vaccine during the First Year of Its Introduction in Brazil: A Cross-Sectional Study |
| Q92968776 | Vaccination for the control of childhood bacterial pneumonia - Haemophilus influenzae type b and pneumococcal vaccines |
| Q26799457 | Vaccination of adolescents with chronic medical conditions: Special considerations and strategies for enhancing uptake |
| Q91881956 | Vaccination timeliness and delay in low- and middle-income countries: a systematic review of the literature, 2007-2017 |
| Q37613609 | Why do we need a systematic review of pneumococcal conjugate vaccine dosing schedules? |
| Q91939911 | [Meningitis caused by Streptococcus pneumoniae serotype 7a in an infant vaccinated with two doses of 13-valent pneumococcal conjugate vaccine: a case study] |
Search more.